Pages that link to "Q71574461"

The following pages link to Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis (Q71574461):

Displaying 36 items.

• Hormone therapy for preventing cardiovascular disease in post-menopausal women (Q24187326) (← links)
• Vitamin D supplementation for prevention of mortality in adults (Q24201160) (← links)
• Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women (Q24244146) (← links)
• Treatment of osteoporosis with calcium and vitamin D. Systematic review (Q30898904) (← links)
• Pharmacological management of osteoporosis in postmenopausal women: a comparative review (Q33795849) (← links)
• Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution (Q33909569) (← links)
• Calcium supplementation and postmenopausal bone loss. (Q34553488) (← links)
• Regional and total skeletal measurements in the early postmenopause (Q35576193) (← links)
• Calcium supplementation of the diet--II (Q35707801) (← links)
• Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation (Q35837088) (← links)
• Does postmenopausal bone loss respond to estrogen replacement therapy independent of bone loss rate? (Q36619938) (← links)
• Estrogens in the prevention and treatment of postmenopausal osteoporosis: a review (Q39543905) (← links)
• Use of calciferol and its metabolites and analogues in osteoporosis. Current status (Q39554946) (← links)
• Osteoporosis: the state of the art in 1987: a review (Q39682122) (← links)
• Osteoporosis. An update on management. (Q40198749) (← links)
• The role of vitamin D and calcium supplementation in the prevention of osteoporotic fractures in the elderly (Q40430742) (← links)
• Osteoporosis: trials and tribulations (Q41597046) (← links)
• Role of vitamin D metabolites in the prevention of the osteopenia induced by ovariectomy in the axial and appendicular skeleton of the rat. (Q44226293) (← links)
• Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis (Q44458263) (← links)
• Prevention of post-menopausal bone loss with 1 alpha-hydroxy vitamin D3. A three-year prospective study (Q45802161) (← links)
• Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial (Q48495381) (← links)
• Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss? (Q51632912) (← links)
• Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats (Q68182345) (← links)
• Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause (Q70175084) (← links)
• Serum vitamin D metabolites in younger and elderly postmenopausal women (Q70470314) (← links)
• The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3 (Q70708506) (← links)
• Postmenopausal osteoporosis (Q71642102) (← links)
• Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis (Q72132578) (← links)
• Treatment of osteoporotic fracture (Q72569357) (← links)
• Treatment of osteoporosis with vitamin D3 (Q72961489) (← links)
• The importance of genetic and nutritional factors in responses to vitamin D and its analogs in osteoporotic patients (Q73067493) (← links)
• The management of osteoporosis (Q73509254) (← links)
• Prevention of postmenopausal bone loss by low and conventional doses of calcitriol or conjugated equine estrogen (Q73543377) (← links)
• Treatment of osteoporosis with vitamin D (Q74425513) (← links)
• Osteoporosis: Part II. Prevention of Bone Loss and Fractures in Women and Risks of Menopausal Estrogen Therapy (Q81882054) (← links)
• Postmenopausal osteoporosis (Q93809572) (← links)